Arabic Archives - Sidra Medicine

Wesam Khalafallah

Dr. Wesam Khalafallah is a Specialist in Pediatric Neurosurgery at Sidra Medicine, where he has been practicing since 2019. He completed a two-year Pediatric Neurosurgery Fellowship at Sidra Medicine in 2023, gaining advanced expertise in the management of complex neurological conditions in children.

Dr. Khalafallah earned his medical degree from Cairo University in Egypt and completed his neurosurgery residency at Jordan University Hospital. He holds certification from both the Jordanian Board of Neurosurgery and the Arab Board of Neurosurgery. His clinical practice focuses on delivering safe, evidence-based, and patient-centered neurosurgical care for pediatric patients.

In addition to his clinical responsibilities, Dr. Khalafallah is actively involved in medical education. He regularly teaches medical students and trainees and has participated as a speaker at pediatric and neurosurgery conferences. He is committed to improving outcomes for children through compassionate care and the use of modern surgical techniques.

11 February, 2026

Sidra Medicine Sets a New Benchmark as Only Organisation in Middle East and Europe to Reach HIMSS DIAM Stage 6

Sidra Medicine, a member of Qatar Foundation, has reached a significant milestone in its digital transformation journey, with formal validation of achieving Stage 6 in both HIMSS EMRAM and HIMSS DIAM.

4 February, 2026

Sidra Medicine Signs MoU with Builders VC MENA to Advance Healthcare Innovation

Sidra Medicine has signed a Memorandum of Understanding (MoU) with Builders VC MENA. The MoU is aimed at strengthening collaboration in healthcare innovation, supporting the development of emerging medical technologies,

22 January, 2026

Msheireb Museums and Sidra Medicine Kick Off 2026 Science Café Series on Stem Cells

Msheireb Museums and Sidra Medicine hosted the first Science Café session of 2026, marking the third year of their collaboration to bring scientific knowledge closer to the public. The session, titled Stem Cells in Precision Medicine: From Research to Reality, took place at Bin Jelmood House, Msheireb Museums, on Wednesday.

20 January, 2026

Sidra Medicine and King’s College London Joint Research Sheds Light on Genetic Diversity in Qatar

Sidra Medicine and King’s College London have produced the most detailed map to date of large-scale genomic differences in the Qatari population. The research, funded by Qatar Research, Development and Innovation Council, provides a clearer picture of the genetic diversity of Arabs and the relationships between genetic variations and health and disease.

30 December, 2025

Sidra Medicine Announces Regional First in Access to Sepiapterin Treatment for Phenylketonuria (PKU)

Sidra Medicine has become the first hospital in the Middle East to facilitate access to sepiapterin, an advanced pharmacological treatment for patients living with Phenylketonuria (PKU). With this achievement, Qatar is now the third country globally—after Germany and the United States—to administer sepiapterin through regulated clinical and governance pathways.

24 December, 2025

Sidra Medicine Performs Qatar’s First Pediatric Allogeneic Stem Cell Transplantation

Sidra Medicine has successfully completed its first pediatric allogeneic hematopoietic stem cell transplantation (HSCT), marking an important step forward in the hospital’s mission to deliver advanced, life-saving care for children with complex and high-risk conditions.

14 December, 2025

Sidra Medicine Announces the 10th Qatar Pediatric Emergency Medicine International Conference (QPEM 2026)

Sidra Medicine is pleased to announce the 10th edition of the Qatar Pediatric Emergency Medicine International Conference (QPEM 2026), taking place virtually from 16–18 January 2026. The milestone edition reflects Sidra Medicine’s continued commitment to advancing high-quality, safe, and patient-centred emergency care for children across Qatar and the region.

5 December, 2025

PMFG 2025 Marks Major Milestone for Precision Medicine in Qatar

The Precision Medicine and the Future of Genomics (PMFG) Summit 2025 successfully concluded after three days of high-level discussions, scientific exchange, and strategic collaboration, new international partnerships = bringing together global leaders, start ups and young scientists in genomics, healthcare innovation, and biomedical research.

4 December, 2025

PMFG 2025 Showcases Qatar’s Strength in AI in Genomics

The third and final day of the Precision Medicine and Future of Genomics Summit 2025 by Sidra Medicine put the spotlight on Qatar's leadership in utilizing advanced genomics and artificial intelligence for the study of rare diseases.